Marcin Wojnar
Overview
Explore the profile of Marcin Wojnar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
133
Citations
1518
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mach A, Wnorowska A, Siwek M, Wojnar M, Radziwon-Zaleska M
Front Pharmacol
. 2025 Jan;
15():1518739.
PMID: 39840091
Background: Due to its exceptional effectiveness, clozapine (CLO), whose metabolite is norclozapine (NCLO), is a drug of choice in the management of treatment-resistant schizophrenia. The purpose of this study was...
2.
Berent D, Wojnar M
Arch Med Sci
. 2024 Jul;
20(3):769-789.
PMID: 39050174
Introduction: The present study evaluated whether adverse childhood experiences (ACEs) are significantly and independently associated with six key outcomes in the Polish general population: (1) lifetime suicide attempt, (2) self-mutilation,...
3.
Zaorska J, Skrzeszewski J, Kobylinski P, Trucco E, Wojnar M, Kopera M, et al.
Alcohol Alcohol
. 2024 Jun;
59(4).
PMID: 38864292
Aims: The objective of the current study was to describe and analyse associations between childhood emotional abuse, severity of depressive symptoms, and analgesic expectations of drinking in individuals with alcohol...
4.
Mach A, Wnorowska A, Siwek M, Wojnar M, Radziwon-Zaleska M
Front Pharmacol
. 2024 Apr;
15:1356813.
PMID: 38601469
Background: Clozapine (CLO) is a very effective antipsychotic, whose use is associated with dose-dependent risk of complications. Due to high interindividual variability in CLO metabolism, there is a need to...
5.
Bramness J, Leonhardt M, Dom G, Batalla A, Florez Menendez G, Mann K, et al.
Eur Addict Res
. 2023 Aug;
30(3):127-137.
PMID: 37557089
Introduction: Training in addiction medicine and addiction psychology is essential to ensure the quality of treatment for patients with substance use disorders. Some earlier research has shown varying training between...
6.
Carver H, Ciolompea T, Conway A, Kilian C, McDonald R, Meksi A, et al.
Front Public Health
. 2023 Aug;
11:1201967.
PMID: 37529435
Since March 2020, the COVID-19 pandemic has had a disproportionately high toll on vulnerable populations, coinciding with increased prevalence of alcohol-and drug-related deaths and pre-existing societal issues such as rising...
7.
Wojnar M, Wierzbinski P, Samochowiec J, Rymaszewska J, Filipiak K, Wichniak A, et al.
Psychiatr Pol
. 2023 Jun;
58(3):419-431.
PMID: 37370219
The development of treatment methods for nicotine dependence has progressed slowly because people with psychiatric disorders are usually excluded from participating in clinical trials. There are several therapeutic options to...
8.
Wojnar M, Wierzbinski P, Samochowiec J, Rymaszewska J, Filipiak K, Wichniak A, et al.
Psychiatr Pol
. 2023 Jun;
58(3):403-418.
PMID: 37370218
Smoking and nicotine dependence are still one of the main reasons for a number of serious and life-shortening somatic diseases. At the same time, they are more prevalent in mentally...
9.
Konopko M, Bienkowski P, Wojnar M, Samochowiec J, Ryglewicz D, Sienkiewicz-Jarosz H
Postep Psychiatr Neurol
. 2023 Apr;
30(3):162-169.
PMID: 37082773
Purpose: The aim of the present study was to assess attitudes of Polish neurologists towards cigarette smoking and their real-life anti-smoking practices. Methods: A study questionnaire was constructed, and distributed...
10.
Dominiak M, Gedek A, Sikorska M, Mierzejewski P, Wojnar M, Antosik-Wojcinska A
Pharmaceuticals (Basel)
. 2023 Jan;
16(1).
PMID: 36678565
The effects of acetylsalicylic acid (ASA) on mood disorders (MD) and on inflammatory parameters in preclinical and clinical studies have not yet been comprehensively evaluated. The aim of this study...